A 30-year-old woman is diagnosed with Stage II ER-positive invasive ductal breast carcinoma. Which adjuvant therapy is typically indicated for ER-posi...

Question

A 30-year-old woman is diagnosed with Stage II ER-positive invasive ductal breast carcinoma. Which adjuvant therapy is typically indicated for ER-positive disease?

Accepted Answer

Tamoxifen or aromatase inhibitor

Answer

Chemotherapy alone

Answer

Trastuzumab (Herceptin)

Answer

Radiotherapy alone

Answer

No adjuvant therapy needed

ukmla MCQ (SBA): Breast Carcinoma

A 30-year-old woman is diagnosed with Stage II ER-positive invasive ductal breast carcinoma. Which adjuvant therapy is typically indicated for ER-positive disease?